Ligand validation:5L69

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5L69_MES_K_303	25%	11%	0.253	0.888	2.31	1.9	1	5	0	0	100%	0.5
5L69_MES_Y_302	16%	18%	0.317	0.887	2.29	1.28	1	3	0	0	100%	0.9
5L6B_MES_V_302	39%	15%	0.235	0.941	2.17	1.58	1	2	1	0	100%	1
5L67_MES_K_303	35%	15%	0.212	0.903	2.34	1.47	1	3	2	0	100%	0.5
5L68_MES_H_302	34%	13%	0.245	0.931	2.05	1.87	1	3	2	0	100%	0.9
5L5D_MES_H_302	34%	18%	0.253	0.936	2.22	1.32	1	3	0	0	100%	1
5L5J_MES_H_302	33%	10%	0.253	0.935	2.38	1.99	1	4	4	0	100%	0.8
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.